The Evolution Of MRI Probes: From The Initial Development To State-Of-The-Art Applications

NMR in Biomedicine

Volumn 26, Issue 7, 2013, Pages 725-727

  Mulder, Willem J M ^a,b   Mcmahon, Michael T ^c,d   Nicolay, Klaas ^e  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KENNEDY KRIEGER INSTITUTE   (United States)

^e EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CONTRAST MEDIUM; FLUORESCENT DYE; GADOLINIUM PENTETATE MEGLUMINE; LIPOSOME; NANOCRYSTAL; NANOMATERIAL; PENTETIC ACID; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANGIOGENESIS; BOLD SIGNAL; BRAIN TUMOR; CELL FUNCTION; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; ENZYME ACTIVITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; LOW TEMPERATURE; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL INSTRUMENTATION; OPTOGENETICS; PH; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANIMALS; CONTRAST MEDIA; GENES, REPORTER; HUMANS; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MOLECULAR PROBES; OPTOGENETICS;

EID: 84879541665     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2976     Document Type: Editorial

References (48)

1. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex - a potential NMR contrast agent. Am. J. Roentgenol. 1984; 142(3): 619-624.
2. Carr DH, Brown J, Bydder GM, Steiner RE, Weinmann HJ, Speck U, Hall AS, Young IR. Gadolinium-DTPA as a contrast agent in MRI - initial clinical-experience in 20 patients. Am. J. Roentgenol. 1984; 143(2): 215-224.
3. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219(2): 316-333.
4. Mulder WJM, Strijkers GJ, van Tilborg GAF, Griffioen AW, Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed. 2006; 19(1): 142-164.
5. Storrs RW, Tropper FD, Li HY, Song CK, Kuniyoshi JK, Sipkins DA, Li KCP, Bednarski MD. Paramagnetic polymerized liposomes - synthesis, characterization, and applications for magnetic-resonance-imaging. J. Am. Chem. Soc. 1995; 117(28): 7301-7306.
6. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KCP. Detection of tumor angiogenesis in vivo by alpha(v)beta(3)-targeted magnetic resonance imaging. Nat. Med. 1998; 4(5): 623-626.
7. Langereis S, Geelen T, Grüll H, Strijkers GJ, Nicolay K. Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery. NMR Biomed. 2013; 26(7): 728-744.
8. Penet M-F, Artemov D, Farahani K, Bhujwalla ZM. MR-eyes for cancer: looking within an impenetrable disease. NMR Biomed. 2013; 26(7): 745-755.
9. Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, Wittenberg J, Ferrucci JT. Superparamagnetic iron-oxide - clinical-application as a contrast agent for MR imaging of the liver. Radiology 1988; 168(2): 297-301.
10. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron-oxide - pharmacokinetics and toxicity. Am. J. Roentgenol. 1989; 152(1): 167-173.
11. Heidt T, Nahrendorf M. Multimodal iron oxide nanoparticles for hybrid biomedical imaging. NMR Biomed. 2013; 26(7): 756-765.
12. Cormode DP, Sanchez-Gaytan BL, Mieszawska AJ, Fayad ZA, Mulder WJM. Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality. NMR Biomed. 2013; 26(7): 766-780.
13. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 2000; 18(3): 321-325.
14. Tu C, Louie AY. Strategies for the development of gadoliniumbased 'q'-activatable MRI contrast agents. NMR Biomed. 2013; 26(7): 781-787.
15. Becerra LR, Gerfen GJ, Temkin RJ, Singel DJ, Griffin RG. Dynamic nuclear-polarization with a cyclotron-resonance maser at 5-T. Phys. Rev. Lett. 1993; 71(21): 3561-3564.
16. Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of >10, 000 times in liquid-state NMR. Proc. Natl. Acad. Sci. USA 2003; 100(18): 10 158-10 163.
17. Bachert P, Schad LR, Bock M, Knopp MV, Ebert M, Grossmann T, Heil W, Hofmann D, Surkau R, Otten EW. Nuclear magnetic resonance imaging of airways in humans with use of hyperpolarized He-3. Magn. Reson. Med. 1996; 36(2): 192-196.
18. Albert MS, Cates GD, Driehuys B, Happer W, Saam B, Springer CS, Wishnia A. Biological magnetic-resonance-imaging using laser polarized Xe-129. Nature 1994; 370(6486): 199-201.
19. Navon G, Song YQ, Room T, Appelt S, Taylor RE, Pines A. Enhancement of solution NMR and MRI with laser-polarized xenon. Science 1996; 271(5257): 1848-1851.
20. Witte C, Schröder L. NMR of hyperpolarised probes. NMR Biomed. 2013; 26(7): 788-802.
21. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat. Neurosci. 2005; 8(9): 1263-1268.
22. Li N, Downey JE, Bar-Shir A, Gilad AA, Walczak P, Kim H, Joel SE, Pekar JJ, Thakor NV, Pelled G. Optogenetic-guided cortical plasticity after nerve injury. Proc. Natl. Acad. Sci. USA 2011; 108(21): 8838-8843.
23. Airan RD, Li N, Gilad AA, Pelled G. Genetic tools to manipulate MRI contrast. NMR Biomed. 2013; 26(7): 803-809.
24. Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J. Magn. Reson. 2000; 143(1): 79-87.
25. Aime S, Carrera C, Delli Castelli D, Geninatti Crich S, Terreno E. Tunable imaging of cells labeled with MRI-PARACEST agents. Angew. Chem. Int. Ed. 2005; 44(12): 1813-1815.
26. McMahon MT, Gilad AA, DeLiso MA, Cromer Berman SM, Bulte JWM, van Zijl PCM. New "multicolor" polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn. Reson. Med. 2008; 60(4): 803-812.
27. Ward KM, Balaban RS. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn. Reson. Med. 2000; 44(5): 799-802.
28. McMahon MT, Gilad AA, Zhou J, Sun PZ, Bulte JWM, van Zijl PCM. Quantifying exchange rates in chemical exchange saturation transfer agents using the saturation time and saturation power dependencies of the magnetization transfer effect on the magnetic resonance imaging signal (QUEST and QUESP): pH calibration for poly-L-lysine and a starburst dendrimer. Magn. Reson. Med. 2006; 55(4): 836-847.
29. Liu G, Song X, Chan KWY, McMahon MT. Nuts and bolts of chemical exchange saturation transfer MRI. NMR Biomed. 2013; 26(7): 810-828.
30. Soesbe TC, Wu Y, Sherry AD. Advantages of paramagnetic chemical exchange saturation transfer (CEST) complexes having slow to intermediate water exchange properties as responsive MRI agents. NMR Biomed. 2013; 26(7): 829-838.
31. Delli Castelli D, Terreno E, Longo D, Aime S. Nanoparticle-based chemical exchange saturation transfer (CEST) agents. NMR Biomed. 2013; 26(7): 839-849.
32. Schroder L, Lowery TJ, Hilty C, Wemmer DE, Pines A. Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor. Science 2006; 314(5798): 446-449.
33. Bulte JWM, Ma LD, Magin RL, Kamman RL, Hulstaert CE, Go KG, The TH, Deleij L. Selective MR imaging of labeled human peripheral-blood mononuclear-cells by liposome mediated incorporation of dextran-magnetite particles. Magn. Reson. Med. 1993; 29(1): 32-37.
34. Bulte JWM, Zhang SC, van Gelderen P, Herynek V, Jordan EK, Duncan ID, Frank JA. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc. Natl. Acad. Sci. USA 1999; 96(26): 15 256-15 261.
35. de Vries IJM, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC, Oyen WJG, Bonenkamp JJ, Boezeman JB, Adema GJ, Bulte JWM, Scheenen TWJ, Punt CJA, Heerschap A, Figdor CG. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 2005; 23(11): 1407-1413.
36. Arifin DR, Kedziorek DA, Fu Y, Chan KWY, McMahon MT, Weiss CR, Kraitchman DL, Bulte JWM. Microencapsulated cell tracking. NMR Biomed. 2013; 26(7): 850-859.
37. Bulte JWM. Hot spot MRI emerges from the background. Nat. Biotechnol. 2005; 23(8): 945-946.
38. Ahrens ET, Flores R, Xu HY, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat. Biotechnol. 2005; 23(8): 983-987.
39. Ahrens ET, Zhong J. In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection. NMR Biomed. 2013; 26(7): 860-871.
40. Vandsburger MH, Radoul M, Cohen B, Neeman M. MRI reporter genes: applications for imaging of cell survival, proliferation, migration and differentiation. NMR Biomed. 2013; 26(7): 872-884.
41. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 2005; 7(2): 109-117.
42. Genove G, DeMarco U, Xu HY, Goins WF, Ahrens ET. A new transgene reporter for in vivo magnetic resonance imaging. Nat. Med. 2005; 11(4): 450-454.
43. Gilad AA, McMahon MT, Walczak P, Winnard PT, Raman V, van Laarhoven HWM, Skoglund CM, Bulte JWM, van Zijl PCM. Artificial reporter gene providing MRI contrast based on proton exchange. Nat. Biotechnol. 2007; 25(2): 217-219.
44. Lanza GM, Winter PM, Caruthers SD, Hughes MS, Hu G, Schmieder AH, Wickline SA. Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions. Angiogenesis 2010; 13(2): 189-202.
45. Skajaa T, Cormode DP, Falk E, Mulder WJM, Fisher EA, Fayad ZA. High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2010; 30(2): 169-176.
46. Glickson JD, Lund-Katz S, Zhou R, Choi H, Chen IW, Li H, Corbin I, Popov AV, Cao WG, Song LP, Qi CZ, Marotta D, Nelson DS, Chen J, Chance B, Zheng G. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents. Mol. Imaging 2008; 7(2): 101-110.
47. Bruns OT, Ittrich H, Peldschus K, Kaul MG, Tromsdorf UI, Lauterwasser J, Nikolic MS, Mollwitz B, Merkell M, Bigall NC, Sapra S, Reimer R, Hohenberg H, Weller H, Eychmuller A, Adam G, Beisiegel U, Heeren J. Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals. Nat. Nanotechnol. 2009; 4(3): 193-201.
48. Ng KK, Lovell JF, Zheng G. Lipoprotein-inspired nanoparticles for cancer theranostics. Acc. Chem. Res. 2011; 44(10): 1105-1113.